SAFETY AND TOLERABILITY OF PUR1800, AN ORALLY INHALED NARROW SPECTRUM KINASE INHIBITOR, IN PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD).